Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

• DOI: 10.6004/jnccn.2022.0030
• Publication Date: 2022-06-17T18:17:27Z
• Authors: William J. Gradishar; Meena S. Moran; Jame Abraham; Rebecca Aft; Doreen Agnese; Kimberly H. Allison; Bethany Anderson; Harold J. Burstein; Helen Chew; Chau Dang; Anthony D. Elias; Sharon H. Giordano; Matthew P. Goetz; Lori J. Goldstein; Sara A. Hurvitz; Steven J. Isakoff; Rachel C. Jankowitz; Sara H. Javid; Jairam Krishnamurthy; Marilyn Leitch; Janice Lyons; Joanne Mortimer; Sameer A. Patel; Lori J. Pierce; Laura H. Rosenberger; Hope S. Rugo; Amy Sitapati; Karen Lisa Smith; Mary Lou Smith; Hatem Soliman; Erica M. Stringer...; Melinda L. Telli; John H. Ward; Kari B. Wisinski; Jessica S. Young; Jennifer Burns; Rashmi Kumar
• Keywords: Clinical Practice; Clinical Oncology; Inflammatory breast cancer

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines Breast Cancer include recommendations clinical management of carcinoma in situ, cancer, Paget disease, phyllodes tumor, inflammatory during pregnancy. content featured this issue focuses on the overall ductal situ workup locoregional early stage cancer. For full version Cancer, visit NCCN.org .